BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vainer N, Dehlendorff C, Johansen JS. Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer. Oncotarget. 2018;9:29820-29841. [PMID: 30038723 DOI: 10.18632/oncotarget.25661] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Stasiewicz M, Kwaśniewski M, Karpiński TM. Microbial Associations with Pancreatic Cancer: A New Frontier in Biomarkers. Cancers (Basel) 2021;13:3784. [PMID: 34359685 DOI: 10.3390/cancers13153784] [Reference Citation Analysis]
2 Qiu J, Wang L, Liu W, Wang J, Zhao E, Zhou F, Ji X, Wang L, Xia Z, Wang W, Lin MC, Liu L, Huang Y, Jiang B. Apigenin Inhibits IL-6 Transcription and Suppresses Esophageal Carcinogenesis. Front Pharmacol 2019;10:1002. [DOI: 10.3389/fphar.2019.01002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
3 Karstens KF, Kempski J, Giannou AD, Freiwald E, Reeh M, Tachezy M, Izbicki JR, Lohse AW, Gagliani N, Huber S, Pelczar P. Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomas. PLoS One 2020;15:e0231833. [PMID: 32298379 DOI: 10.1371/journal.pone.0231833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wang X, Li J, Liu W, Zhang X, Xue L. The diagnostic value of interleukin 6 as a biomarker for gastric cancer: A meta-analysis and systematic review. Medicine 2021;100:e27945. [DOI: 10.1097/md.0000000000027945] [Reference Citation Analysis]
5 Schokker S, van der Woude SO, van Kleef JJ, van Zoen DJ, van Oijen MGH, Mearadji B, Beenen LFM, Stroes CI, Waasdorp C, Jibodh RA, Creemers A, Meijer SL, Hooijer GKJ, Punt CJA, Bijlsma MF, van Laarhoven HWM. Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study). Cancers (Basel) 2019;11:E827. [PMID: 31207904 DOI: 10.3390/cancers11060827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Zhou Y, Zang Y, Yang Y, Xiang J, Chen Z. Candidate genes involved in metastasis of colon cancer identified by integrated analysis. Cancer Med 2019;8:2338-47. [PMID: 30884206 DOI: 10.1002/cam4.2071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
7 Wu SY, Ho MH, Chang HM, Hsu KF, Yu JC, Chan DC. Long-term oncologic result of laparoscopic versus open gastrectomy for gastric cancer: a propensity score matching analysis. World J Surg Oncol 2021;19:101. [PMID: 33827601 DOI: 10.1186/s12957-021-02217-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Kim J, Yuan C, Babic A, Bao Y, Clish CB, Pollak MN, Amundadottir LT, Klein AP, Stolzenberg-Solomon RZ, Pandharipande PV, Brais LK, Welch MW, Ng K, Giovannucci EL, Sesso HD, Manson JE, Stampfer MJ, Fuchs CS, Wolpin BM, Kraft P. Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. Cancer Epidemiol Biomarkers Prev 2020;29:999-1008. [PMID: 32321713 DOI: 10.1158/1055-9965.EPI-19-1389] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
9 Linares J, Marín-Jiménez JA, Badia-Ramentol J, Calon A. Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy. Front Cell Dev Biol 2020;8:621070. [PMID: 33553157 DOI: 10.3389/fcell.2020.621070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Huang HW, Chang CC, Wang CS, Lin KH. Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development. Cells 2021;10:E67. [PMID: 33406733 DOI: 10.3390/cells10010067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Pop V, Parvu A, Craciun A, Farcas AD, Tomoaia G, Bojan A. Modern markers for evaluating bone disease in multiple myeloma (Review). Exp Ther Med 2021;22:1329. [PMID: 34630683 DOI: 10.3892/etm.2021.10764] [Reference Citation Analysis]
12 Manning AA, Zhao L, Zhu Z, Xiao H, Redington CG, Ding VA, Stewart-Hester T, Bai Q, Dunlap J, Wakefield MR, Fang Y. IL-39 acts as a friend to pancreatic cancer. Med Oncol 2018;36:12. [PMID: 30506430 DOI: 10.1007/s12032-018-1236-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Dhama K, Latheef SK, Dadar M, Samad HA, Munjal A, Khandia R, Karthik K, Tiwari R, Yatoo MI, Bhatt P, Chakraborty S, Singh KP, Iqbal HMN, Chaicumpa W, Joshi SK. Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values. Front Mol Biosci 2019;6:91. [PMID: 31750312 DOI: 10.3389/fmolb.2019.00091] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
14 Calu V, Ionescu A, Stanca L, Geicu OI, Iordache F, Pisoschi AM, Serban AI, Bilteanu L. Key biomarkers within the colorectal cancer related inflammatory microenvironment. Sci Rep 2021;11:7940. [PMID: 33846436 DOI: 10.1038/s41598-021-86941-5] [Reference Citation Analysis]
15 Dettorre GM, Patel M, Gennari A, Pentheroudakis G, Romano E, Cortellini A, Pinato DJ. The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer. ESMO Open 2021;6:100123. [PMID: 33932622 DOI: 10.1016/j.esmoop.2021.100123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yang E, Chua W, Ng W, Roberts TL. Peripheral Cytokine Levels as a Prognostic Indicator in Gastric Cancer: A Review of Existing Literature. Biomedicines 2021;9:1916. [PMID: 34944729 DOI: 10.3390/biomedicines9121916] [Reference Citation Analysis]
17 Chen IM, Willumsen N, Dehlendorff C, Johansen AZ, Jensen BV, Hansen CP, Hasselby JP, Bojesen SE, Pfeiffer P, Nielsen SE, Holländer NH, Yilmaz MK, Karsdal M, Johansen JS. Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer. Int J Cancer 2020;146:2913-22. [PMID: 31642523 DOI: 10.1002/ijc.32751] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
18 Sørensen MS, Colding-Rasmussen T, Horstmann PF, Hindsø K, Dehlendorff C, Johansen JS, Petersen MM. Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities. Cancers (Basel) 2021;13:2833. [PMID: 34200156 DOI: 10.3390/cancers13112833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Shibuki T, Mizuta T, Shimokawa M, Koga F, Ueda Y, Nakazawa J, Komori A, Otsu S, Arima S, Fukahori M, Makiyama A, Taguchi H, Honda T, Mitsugi K, Nio K, Ide Y, Ureshino N, Shirakawa T, Otsuka T. Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study). BMC Cancer 2022;22:19. [PMID: 34980029 DOI: 10.1186/s12885-021-09139-y] [Reference Citation Analysis]
20 Zhang X, Zhu M, Hong Z, Chen C. Co-culturing polarized M2 Thp-1-derived macrophages enhance stemness of lung adenocarcinoma A549 cells. Ann Transl Med 2021;9:709. [PMID: 33987407 DOI: 10.21037/atm-21-1256] [Reference Citation Analysis]
21 Xu B, Zhou NM, Cao WT, Gu SY. Comparative study on operative trauma between microwave ablation and surgical treatment for papillary thyroid microcarcinoma. World J Clin Cases 2018; 6(15): 936-943 [PMID: 30568949 DOI: 10.12998/wjcc.v6.i15.936] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
22 Catani MV, Savini I, Tullio V, Gasperi V. The "Janus Face" of Platelets in Cancer. Int J Mol Sci. 2020;21. [PMID: 31991775 DOI: 10.3390/ijms21030788] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
23 Luo W, Qiu J, Zheng L, Zhang T. Novel therapies targeting hypoxia mechanism to treat pancreatic cancer. Chin J Cancer Res 2021;33:216-31. [PMID: 34158741 DOI: 10.21147/j.issn.1000-9604.2021.02.09] [Reference Citation Analysis]
24 Ternet C, Kiel C. Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage. Cell Commun Signal 2021;19:31. [PMID: 33691728 DOI: 10.1186/s12964-021-00712-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Castillo-salazar M, Sánchez-muñoz F, Springall del Villar R, Navarrete-vázquez G, Hernández-diazcouder A, Mojica-cardoso C, García-jiménez S, Toledano-jaimes C, Bernal-fernández G. Nitazoxanide Exerts Immunomodulatory Effects on Peripheral Blood Mononuclear Cells from Type 2 Diabetes Patients. Biomolecules 2021;11:1817. [DOI: 10.3390/biom11121817] [Reference Citation Analysis]
26 Peltonen R, Gramkow MH, Dehlendorff C, Osterlund PJ, Johansen JS, Isoniemi H. Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases. PLoS One 2020;15:e0236569. [PMID: 32756596 DOI: 10.1371/journal.pone.0236569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Palmquist C, Dehlendorff C, Calatayud D, Hansen CP, Hasselby JP, Johansen JS. Prediction of Unresectability and Prognosis in Patients Undergoing Surgery on Suspicion of Pancreatic Cancer Using Carbohydrate Antigen 19-9, Interleukin 6, and YKL-40. Pancreas 2020;49:53-61. [PMID: 31856080 DOI: 10.1097/MPA.0000000000001466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Nazha B, Bilen MA. Circulating interleukin 6, androgen deprivation therapy, and fatigue in prostate cancer: Is inflammation the link? Cancer 2021;127:1371-3. [PMID: 33378089 DOI: 10.1002/cncr.33398] [Reference Citation Analysis]
29 Hamfjord J, Guren TK, Dajani O, Johansen JS, Glimelius B, Sorbye H, Pfeiffer P, Lingjærde OC, Tveit KM, Kure EH, Pallisgaard N, Spindler KG. Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy. Ann Oncol 2019;30:1088-95. [PMID: 31046124 DOI: 10.1093/annonc/mdz139] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
30 Hermunen K, Soveri LM, Boisen MK, Mustonen HK, Dehlendorff C, Haglund CH, Johansen JS, Osterlund P. Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer. Acta Oncol 2020;59:1416-23. [PMID: 32790589 DOI: 10.1080/0284186X.2020.1800086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Abolfathi H, Sheikhpour M, Shahraeini SS, Khatami S, Nojoumi SA. Studies in lung cancer cytokine proteomics: a review. Expert Rev Proteomics 2021;18:49-64. [PMID: 33612047 DOI: 10.1080/14789450.2021.1892491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Jarrin Jara MD, Gautam AS, Peesapati VSR, Sadik M, Khan S. The Role of Interleukin-6 and Inflammatory Cytokines in Pancreatic Cancer-Associated Depression. Cureus 2020;12:e9969. [PMID: 32850269 DOI: 10.7759/cureus.9969] [Reference Citation Analysis]
33 Ye C, Yano H, Workman CJ, Vignali DAA. Interleukin-35: Structure, Function and Its Impact on Immune-Related Diseases. J Interferon Cytokine Res 2021;41:391-406. [PMID: 34788131 DOI: 10.1089/jir.2021.0147] [Reference Citation Analysis]
34 Rasmussen LS, Yilmaz MK, Falkmer UG, Poulsen LØ, Bøgsted M, Christensen HS, Bojesen SE, Jensen BV, Chen IM, Johansen AZ, Hansen CP, Hasselby JP, Holländer N, Nielsen SE, Andersen F, Bjerregaard JK, Pfeiffer P, Johansen JS. Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer. Eur J Cancer 2021;144:72-80. [PMID: 33341448 DOI: 10.1016/j.ejca.2020.10.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
35 Harun-Or-Roshid M, Ali MB, Jesmin, Mollah MNH. Statistical meta-analysis to investigate the association between the Interleukin-6 (IL-6) gene polymorphisms and cancer risk. PLoS One 2021;16:e0247055. [PMID: 33684135 DOI: 10.1371/journal.pone.0247055] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
36 de Sousa E, Lérias JR, Beltran A, Paraschoudi G, Condeço C, Kamiki J, António PA, Figueiredo N, Carvalho C, Castillo-Martin M, Wang Z, Ligeiro D, Rao M, Maeurer M. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery. Front Immunol 2021;12:592031. [PMID: 34335558 DOI: 10.3389/fimmu.2021.592031] [Reference Citation Analysis]
37 Akram M, Daniyal M, Sultana S, Owais A, Akhtar N, Zahid R, Said F, Bouyahya A, Ponomarev E, Ali Shariat M, Thiruvengadam M. Traditional and modern management strategies for rheumatoid arthritis. Clin Chim Acta 2021;512:142-55. [PMID: 33186593 DOI: 10.1016/j.cca.2020.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Bittencourt MLF, Rodrigues RP, Kitagawa RR, Gonçalves RCR. The gastroprotective potential of silibinin against Helicobacter pylori infection and gastric tumor cells. Life Sci 2020;256:117977. [PMID: 32603822 DOI: 10.1016/j.lfs.2020.117977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Farmer JR. Testing Immune-Related Adverse Events in Cancer Immunotherapy. Clin Lab Med 2019;39:669-83. [PMID: 31668277 DOI: 10.1016/j.cll.2019.07.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kjaergaard AD, Chen IM, Johansen AZ, Nordestgaard BG, Bojesen SE, Johansen JS. Inflammatory Biomarker Score Identifies Patients with Six-Fold Increased Risk of One-Year Mortality after Pancreatic Cancer. Cancers (Basel) 2021;13:4599. [PMID: 34572824 DOI: 10.3390/cancers13184599] [Reference Citation Analysis]
41 Pressnall MM, Huang A, Groer CE, Huayamares SG, Laird Forrest M, Berkland CJ. Glatiramer acetate enhances tumor retention and innate activation of immunostimulants. Int J Pharm 2021;605:120812. [PMID: 34144136 DOI: 10.1016/j.ijpharm.2021.120812] [Reference Citation Analysis]
42 Kim J, Lee J, Oh JH, Chang HJ, Sohn DK, Shin A, Kim J. Circulating Interleukin-6 Level, Dietary Antioxidant Capacity, and Risk of Colorectal Cancer. Antioxidants (Basel) 2019;8:E595. [PMID: 31795177 DOI: 10.3390/antiox8120595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Sadighbayan D, Sadighbayan K, Khosroushahi AY, Hasanzadeh M. Recent advances on the DNA-based electrochemical biosensing of cancer biomarkers: Analytical approach. TrAC Trends in Analytical Chemistry 2019;119:115609. [DOI: 10.1016/j.trac.2019.07.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
44 Chen G, Huang C, Liu Y, Chen T, Huang R, Liang M, Zhang J, Xu H. A Network Pharmacology Approach to Uncover the Potential Mechanism of Yinchensini Decoction. Evid Based Complement Alternat Med 2018;2018:2178610. [PMID: 30671125 DOI: 10.1155/2018/2178610] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
45 Pagliara V, Nasso R, Di Donato P, Finore I, Poli A, Masullo M, Arcone R. Lemon Peel Polyphenol Extract Reduces Interleukin-6-Induced Cell Migration, Invasiveness, and Matrix Metalloproteinase-9/2 Expression in Human Gastric Adenocarcinoma MKN-28 and AGS Cell Lines. Biomolecules 2019;9:E833. [PMID: 31817563 DOI: 10.3390/biom9120833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
46 Xia T, Li J, Ren X, Liu C, Sun C. Research progress of phenolic compounds regulating IL-6 to exert antitumor effects. Phytother Res 2021. [PMID: 34427003 DOI: 10.1002/ptr.7258] [Reference Citation Analysis]
47 Kotru S, Klimuntowski M, Ridha H, Uddin Z, Askhar AA, Singh G, Howlader MMR. Electrochemical sensing: A prognostic tool in the fight against COVID-19. Trends Analyt Chem 2021;136:116198. [PMID: 33518850 DOI: 10.1016/j.trac.2021.116198] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
48 Talib WH, Alsayed AR, Farhan F, Al Kury LT. Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets. Molecules 2020;25:E4282. [PMID: 32961987 DOI: 10.3390/molecules25184282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
49 Tylicka M, Matuszczak E, Kamińska J, Dębek W, Modzelewska B, Kleszczewski T, Dymicka-Piekarska V, Matowicka-Karna J, Karpińska M, Koper-Lenkiewicz OM. Intraoperative Peritoneal Interleukin-6 Concentration Changes in Relation to the High-Mobility Group Protein B1 and Heat Shock Protein 70 Levels in Children Undergoing Cholecystectomy. Mediators Inflamm 2020;2020:9613105. [PMID: 32724297 DOI: 10.1155/2020/9613105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Li Q, Maier SH, Li P, Peterhansl J, Belka C, Mayerle J, Mahajan UM. Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma. Radiat Oncol 2020;15:189. [PMID: 32758252 DOI: 10.1186/s13014-020-01624-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
51 Martínez-Pérez C, Kay C, Meehan J, Gray M, Dixon JM, Turnbull AK. The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer. J Pers Med 2021;11:1073. [PMID: 34834425 DOI: 10.3390/jpm11111073] [Reference Citation Analysis]
52 Vogl M, Rosenmayr A, Bohanes T, Scheed A, Brndiar M, Stubenberger E, Ghanim B. Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation. Cancers (Basel) 2021;13:658. [PMID: 33562138 DOI: 10.3390/cancers13040658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
53 Dong Y, Hao L, Fang K, Han XX, Yu H, Zhang JJ, Cai LJ, Fan T, Zhang WD, Pang K, Ma WM, Wang XT, Han CH. A network pharmacology perspective for deciphering potential mechanisms of action of Solanum nigrum L. in bladder cancer. BMC Complement Med Ther 2021;21:45. [PMID: 33494738 DOI: 10.1186/s12906-021-03215-3] [Reference Citation Analysis]
54 Pagliara V, De Rosa M, Di Donato P, Nasso R, D'Errico A, Cammarota F, Poli A, Masullo M, Arcone R. Inhibition of Interleukin-6-Induced Matrix Metalloproteinase-2 Expression and Invasive Ability of Lemon Peel Polyphenol Extract in Human Primary Colon Cancer Cells. Molecules 2021;26:7076. [PMID: 34885656 DOI: 10.3390/molecules26237076] [Reference Citation Analysis]
55 Lehtomäki K, Mustonen H, Kellokumpu-Lehtinen PL, Joensuu H, Hermunen K, Soveri LM, Boisen MK, Dehlendorff C, Johansen JS, Haglund C, Osterlund P. Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer. Cancers (Basel) 2021;13:3892. [PMID: 34359796 DOI: 10.3390/cancers13153892] [Reference Citation Analysis]
56 Tsujimoto H, Kobayashi M, Sugasawa H, Ono S, Kishi Y, Ueno H. Potential mechanisms of tumor progression associated with postoperative infectious complications. Cancer Metastasis Rev 2021;40:285-96. [PMID: 33389285 DOI: 10.1007/s10555-020-09945-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Koper-Lenkiewicz OM, Dymicka-Piekarska V, Milewska AJ, Zińczuk J, Kamińska J. The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location. Diagnostics (Basel) 2021;11:1382. [PMID: 34441316 DOI: 10.3390/diagnostics11081382] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Kujundžić RN, Stepanić V, Milković L, Gašparović AČ, Tomljanović M, Trošelj KG. Curcumin and its Potential for Systemic Targeting of Inflamm-Aging and Metabolic Reprogramming in Cancer. Int J Mol Sci 2019;20:E1180. [PMID: 30857125 DOI: 10.3390/ijms20051180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]